These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10505101)

  • 1. Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype.
    Selmayr M; Strehl J; Kremer JP; Kremmer E; Doenecke A; Hallek M; Menzel H; Thielemans K; Thierfelder S; Mocikat R
    Gene Ther; 1999 May; 6(5):778-84. PubMed ID: 10505101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell lymphoma idiotypes chimerized by gene targeting can induce tumor immunity.
    Selmayr M; Menzel H; Kremer JP; Thierfelder S; Mocikat R
    Cancer Gene Ther; 2000 Mar; 7(3):501-6. PubMed ID: 10766357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity.
    Levitsky HI; Montgomery J; Ahmadzadeh M; Staveley-O'Carroll K; Guarnieri F; Longo DL; Kwak LW
    J Immunol; 1996 May; 156(10):3858-65. PubMed ID: 8621924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma.
    Tao MH; Levy R
    Nature; 1993 Apr; 362(6422):755-8. PubMed ID: 8469286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid expression of vaccine proteins for B-cell lymphoma in a cell-free system.
    Yang J; Kanter G; Voloshin A; Michel-Reydellet N; Velkeen H; Levy R; Swartz JR
    Biotechnol Bioeng; 2005 Mar; 89(5):503-11. PubMed ID: 15669088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
    Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
    Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiotype-cytokine fusion proteins as cancer vaccines. Relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor.
    Chen TT; Tao MH; Levy R
    J Immunol; 1994 Nov; 153(10):4775-87. PubMed ID: 7525715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection.
    Syrengelas AD; Levy R
    J Immunol; 1999 Apr; 162(8):4790-5. PubMed ID: 10202021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nine-amino acid peptide from IL-1beta augments antitumor immune responses induced by protein and DNA vaccines.
    Hakim I; Levy S; Levy R
    J Immunol; 1996 Dec; 157(12):5503-11. PubMed ID: 8955200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J; Wu JH; Bouganim N; Galipeau J
    Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of autoantibody responses to GM-CSF by hyperimmunization with an Id-GM-CSF fusion protein.
    Chen TT; Levy R
    J Immunol; 1995 Apr; 154(7):3105-17. PubMed ID: 7897201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prime-boost vaccines encoding an intracellular idiotype/GM-CSF fusion protein induce protective cell-mediated immunity in murine pre-B cell leukemia.
    Pasquini S; Peralta S; Missiaglia E; Carta L; Lemoine NR
    Gene Ther; 2002 Apr; 9(8):503-10. PubMed ID: 11948375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
    Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of anti-tumor immunity by lyophilized myeloma cells secreting GM-CSF.
    Wu S; Yuan D; Liu JN; Tan XY
    Oncol Rep; 2007 Jan; 17(1):129-33. PubMed ID: 17143489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity.
    Wang L; Qi X; Sun Y; Liang L; Ju D
    Cancer Gene Ther; 2002 Oct; 9(10):819-24. PubMed ID: 12224022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
    J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines.
    Withoff S; Glazenburg KL; van Veen ML; Kraak MM; Hospers GA; Störkel S; de Vries EG; Wilschut J; Daemen T
    Gene Ther; 2001 Oct; 8(20):1515-23. PubMed ID: 11704811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.